Abilify and Dysarthria

This page shows results related to Abilify and Dysarthria from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Abilify and Dysarthria

Age

40-49 Years	34
30-39 Years	23
10-19 Years	22
50-59 Years	21
>60 Years	17
20-29 Years	16
1-9 Years	12
0-12 Months	1

Gender

Male: 37%
Female: 59%
Gender Unknown: 4%

Outcome

What were the most common outcomes of those reporting Dysarthria?

Hospitalization	49
Other	28
Life Threatening	9
Disability	8
Death	2
Required Intervention	2

Reporter

Who most commonly reported Dysarthria?

Consumer	69
Other	41
Physician	28
Pharmacist	4

Therapy

Of those reporting Dysarthria, why were they taking Abilify?

Bipolar Disorder	25
Schizophrenia	22
Depression	16
Psychotic Disorder	7
Delusion	7

Other Medications

Which medications reported to the FDA are most commonly associated with Dysarthria?

Lyrica	587
Tysabri	573
Valtrex	509
Avonex	460
Vioxx	425
	Show More
Seroquel	337
Zyprexa	241
Zometa	193
Rebif	187
Oxycontin	186
Olanzapine	186
Humira	185
Clozaril	176
Abilify	174
Chantix	172
Neurontin	166
Lithium Carbonate	145
Forteo	144
Yasmin	142
Cymbalta	141
Yaz	135
Betaseron	128
Clozapine	127
Botox	124
Remicade	124
Topamax	123
Gilenya	122
Digoxin	121
Methotrexate	120
Metronidazole	120
Aspirin	119
Tegretol	119
Enbrel	112
Risperdal	106
Diovan	104
Paxil	103
Geodon	103
Lamictal	101
Aredia	101
Gabapentin	99
Xanax	98
Lipitor	96
Ambien	93
Metoclopramide	93
Dilantin	91
Cyclophosphamide	90
Morphine Sulfate	89
Effexor Xr	89
Fosamax	84
Duragesic-100	83
Carbamazepine	81

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Abilify, view the complete Abilify adverse event report.

Scientific Publications on Dysarthria

Comments

Share your experience with Abilify and Dysarthria.